FDA Inspection 1036787 — VistaPharm LLC
The FDA completed an inspection of VistaPharm LLC on November 9, 2017 in Largo, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 9, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Largo, FL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)